{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:15:26Z","timestamp":1791288926858,"version":"4.3.0"},"reference-count":44,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12,1]]},"DOI":"10.1210\/me.2010-0256","type":"journal-article","created":{"date-parts":[[2010,10,28]],"date-time":"2010-10-28T02:19:52Z","timestamp":1288232392000},"page":"2382-2391","source":"Crossref","is-referenced-by-count":184,"title":["Research Resource: Transcriptional Profiling Reveals Different Pseudohypoxic Signatures in SDHB and VHL-Related Pheochromocytomas"],"prefix":"10.1210","volume":"24","author":[{"given":"Elena","family":"Lo\u0301pez-Jime\u0301nez","sequence":"first","affiliation":[{"name":"Hereditary Endocrine Cancer Group (E.L.-J., L.J.L.-G., C.M.-C., A.A.d.C., I.L., S.L., A.M., L.I.-P., L.d.l.V., C.R.-A., R.L., M.R., A.C.), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Go\u0301mez-Lo\u0301pez","sequence":"additional","affiliation":[{"name":"Structural Biology and Biocomputing Programme (G.G.-L., C.B., D.G.P.), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Javier","family":"Leandro-Garci\u0301a","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group (E.L.-J., L.J.L.-G., C.M.-C., A.A.d.C., I.L., S.L., A.M., L.I.-P., L.d.l.V., C.R.-A., R.L., M.R., A.C.), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva\u0301n","family":"Mun\u0303oz","sequence":"additional","affiliation":[{"name":"Human Genetics Group (I.M., R.R.), Spanish National Cancer Research Centre, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Schiavi","sequence":"additional","affiliation":[{"name":"Familial Cancer Clinic (F.S., G.O.), Veneto Institute of Oncology, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Montero-Conde","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group (E.L.-J., L.J.L.-G., C.M.-C., A.A.d.C., I.L., S.L., A.M., L.I.-P., L.d.l.V., C.R.-A., R.L., M.R., A.C.), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aguirre A.","family":"de Cubas","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group (E.L.-J., L.J.L.-G., C.M.-C., A.A.d.C., I.L., S.L., A.M., L.I.-P., L.d.l.V., C.R.-A., R.L., M.R., A.C.), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Ramires","sequence":"additional","affiliation":[{"name":"Human Genetics Group (I.M., R.R.), Spanish National Cancer Research Centre, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u0303igo","family":"Landa","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group (E.L.-J., L.J.L.-G., C.M.-C., A.A.d.C., I.L., S.L., A.M., L.I.-P., L.d.l.V., C.R.-A., R.L., M.R., A.C.), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Leskela\u0308","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group (E.L.-J., L.J.L.-G., C.M.-C., A.A.d.C., I.L., S.L., A.M., L.I.-P., L.d.l.V., C.R.-A., R.L., M.R., A.C.), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Maliszewska","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group (E.L.-J., L.J.L.-G., C.M.-C., A.A.d.C., I.L., S.L., A.M., L.I.-P., L.d.l.V., C.R.-A., R.L., M.R., A.C.), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luci\u0301a","family":"Inglada-Pe\u0301rez","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group (E.L.-J., L.J.L.-G., C.M.-C., A.A.d.C., I.L., S.L., A.M., L.I.-P., L.d.l.V., C.R.-A., R.L., M.R., A.C.), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"de la Vega","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group (E.L.-J., L.J.L.-G., C.M.-C., A.A.d.C., I.L., S.L., A.M., L.I.-P., L.d.l.V., C.R.-A., R.L., M.R., A.C.), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Rodri\u0301guez-Antona","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group (E.L.-J., L.J.L.-G., C.M.-C., A.A.d.C., I.L., S.L., A.M., L.I.-P., L.d.l.V., C.R.-A., R.L., M.R., A.C.), 28029 Madrid, Spain"},{"name":"ISCIII Center for Biomedical Research on Rare Diseases (C.R.-A., M.R., A.C.), C Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roci\u0301o","family":"Leto\u0301n","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group (E.L.-J., L.J.L.-G., C.M.-C., A.A.d.C., I.L., S.L., A.M., L.I.-P., L.d.l.V., C.R.-A., R.L., M.R., A.C.), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Bernal","sequence":"additional","affiliation":[{"name":"Structural Biology and Biocomputing Programme (G.G.-L., C.B., D.G.P.), 28029 Madrid, Spain"},{"name":"Endocrinology and Nutrition Service (C.B.), Hospital 12 de Octubre, C Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose\u0301 M.","family":"de Campos","sequence":"additional","affiliation":[{"name":"Neurosurgery Department (J.M.d.C.), Fundacio\u0301n Jime\u0301nez Di\u0301az, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Diez-Tasco\u0301n","sequence":"additional","affiliation":[{"name":"Banco de Tumores (C.D.-T.), Complejo Hospitalario de Leo\u0301n, 24008 Leon, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario F.","family":"Fraga","sequence":"additional","affiliation":[{"name":"Department of Immunology and Oncology (M.F.F.), National Center for Biotechnology, Centro Nacional de Biotecnologi\u0301a-Consejo Superior de Investigaciones Cienti\u0301ficas, Cantoblanco, 28049 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Boullosa","sequence":"additional","affiliation":[{"name":"Structural Biology and Biocomputing Programme (G.G.-L., C.B., D.G.P.), 28029 Madrid, Spain"},{"name":"Endocrinology and Nutrition Service (C.B.), Hospital 12 de Octubre, C Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Pisano","sequence":"additional","affiliation":[{"name":"Structural Biology and Biocomputing Programme (G.G.-L., C.B., D.G.P.), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Opocher","sequence":"additional","affiliation":[{"name":"Familial Cancer Clinic (F.S., G.O.), Veneto Institute of Oncology, 35128 Padua, Italy"},{"name":"Department of Medical and Surgical Sciences (G.O.), University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Robledo","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group (E.L.-J., L.J.L.-G., C.M.-C., A.A.d.C., I.L., S.L., A.M., L.I.-P., L.d.l.V., C.R.-A., R.L., M.R., A.C.), 28029 Madrid, Spain"},{"name":"ISCIII Center for Biomedical Research on Rare Diseases (C.R.-A., M.R., A.C.), C Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Casco\u0301n","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group (E.L.-J., L.J.L.-G., C.M.-C., A.A.d.C., I.L., S.L., A.M., L.I.-P., L.d.l.V., C.R.-A., R.L., M.R., A.C.), 28029 Madrid, Spain"},{"name":"ISCIII Center for Biomedical Research on Rare Diseases (C.R.-A., M.R., A.C.), C Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041200564011600_R1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1175689","article-title":"SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma.","volume":"325","author":"Hao","year":"2009","journal-title":"Science"},{"key":"2019041200564011600_R2","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma.","volume":"19","author":"Burnichon","year":"2010","journal-title":"Hum Mol Genet"},{"key":"2019041200564011600_R3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ng.533","article-title":"Germline mutations in TMEM127 confer susceptibility to pheochromocytoma.","volume":"42","author":"Qin","year":"2010","journal-title":"Nat Genet"},{"key":"2019041200564011600_R4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ccr.2005.06.015","article-title":"Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer.","volume":"8","author":"Lee","year":"2005","journal-title":"Cancer Cell"},{"key":"2019041200564011600_R5","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1101\/gad.1648608","article-title":"The kinesin KIF1B\u03b2 acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor.","volume":"22","author":"Schlisio","year":"2008","journal-title":"Genes Dev"},{"key":"2019041200564011600_R6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1371\/journal.pgen.0010008","article-title":"A HIF1\u03b1 regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas.","volume":"1","author":"Dahia","year":"2005","journal-title":"PLoS Genet"},{"key":"2019041200564011600_R7","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1677\/erc.1.00838","article-title":"Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome.","volume":"11","author":"Eisenhofer","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"2019041200564011600_R8","author":"Favier"},{"key":"2019041200564011600_R9","first-page":"5615","article-title":"Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas.","volume":"63","author":"Gimenez-Roqueplo","year":"2003","journal-title":"Cancer Res"},{"key":"2019041200564011600_R10","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1210\/jc.2006-0423","article-title":"High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing.","volume":"91","author":"Brouwers","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041200564011600_R11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1055\/s-0029-1231025","article-title":"Treatment of malignant pheochromocytoma.","volume":"41","author":"Adjalle\u0301","year":"2009","journal-title":"Horm Metab Res"},{"key":"2019041200564011600_R12","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1128\/MCB.25.13.5675-5686.2005","article-title":"Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.","volume":"25","author":"Raval","year":"2005","journal-title":"Mol Cell Biol"},{"key":"2019041200564011600_R13","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1074\/jbc.M010144200","article-title":"Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia.","volume":"276","author":"Chen","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041200564011600_R14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.devcel.2005.09.010","article-title":"Hypoxia requires notch signaling to maintain the undifferentiated cell state.","volume":"9","author":"Gustafsson","year":"2005","journal-title":"Dev Cell"},{"key":"2019041200564011600_R15","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1158\/0008-5472.CAN-05-2105","article-title":"Nox4 is critical for hypoxia-inducible factor 2-\u03b1 transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma.","volume":"65","author":"Maranchie","year":"2005","journal-title":"Cancer Res"},{"key":"2019041200564011600_R16","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1210\/jc.2006-0920","article-title":"Expression of HIF-1\u03b1, HIF-2\u03b1 (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.","volume":"91","author":"Pollard","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041200564011600_R17","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1158\/0008-5472.CAN-07-5580","article-title":"Cells silenced for SDHB expression display characteristic features of the tumor phenotype.","volume":"68","author":"Cervera","year":"2008","journal-title":"Cancer Res"},{"key":"2019041200564011600_R18","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/onc.2009.12","article-title":"VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo.","volume":"28","author":"Lee","year":"2009","journal-title":"Oncogene"},{"key":"2019041200564011600_R19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jcb.20067","article-title":"Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.","volume":"92","author":"Aprelikova","year":"2004","journal-title":"J Cell Biochem"},{"key":"2019041200564011600_R20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-\u03b1 to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"2019041200564011600_R21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrc2502","article-title":"The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer.","volume":"8","author":"Kaelin Jr","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"2019041200564011600_R22","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","article-title":"HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1\u03b1 in normoxia.","volume":"22","author":"Berra","year":"2003","journal-title":"EMBO J"},{"key":"2019041200564011600_R23","doi-asserted-by":"crossref","first-page":"12410","DOI":"10.1074\/jbc.M608748200","article-title":"EGLN3 prolyl hydroxylase regulates skeletal muscle differentiation and myogenin protein stability.","volume":"282","author":"Fu","year":"2007","journal-title":"J Biol Chem"},{"key":"2019041200564011600_R24","doi-asserted-by":"crossref","first-page":"8927","DOI":"10.1074\/jbc.M109.078600","article-title":"Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-\u03baB-dependent pathway.","volume":"285","author":"Fu","year":"2010","journal-title":"J Biol Chem"},{"key":"2019041200564011600_R25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1053\/j.gastro.2009.09.049","article-title":"Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKK\u03b2 independent of hydroxylase activity.","volume":"138","author":"Xue","year":"2010","journal-title":"Gastroenterology"},{"key":"2019041200564011600_R26","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1158\/1078-0432.CCR-08-0466","article-title":"Identification of an immunogenic CTL epitope of HIFPH3 for immunotherapy of renal cell carcinoma.","volume":"14","author":"Sato","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2019041200564011600_R27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2353\/ajpath.2010.090767","article-title":"Deletion of Von Hippel-Lindau in glomerular podocytes results in glomerular basement membrane thickening, ectopic subepithelial deposition of collagen \u03b11\u03b12\u03b11(IV), expression of neuroglobin, and proteinuria.","volume":"177","author":"Steenhard","year":"2010","journal-title":"Am J Pathol"},{"key":"2019041200564011600_R28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0609.2009.01344.x","article-title":"The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia.","volume":"84","author":"Hatzimichael","year":"2010","journal-title":"Eur J Haematol"},{"key":"2019041200564011600_R29","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1038\/sj.onc.1206666","article-title":"BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF.","volume":"22","author":"Kothari","year":"2003","journal-title":"Oncogene"},{"key":"2019041200564011600_R30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ccr.2004.10.012","article-title":"Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth.","volume":"6","author":"Fei","year":"2004","journal-title":"Cancer Cell"},{"key":"2019041200564011600_R31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ccr.2009.08.013","article-title":"SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling.","volume":"16","author":"Kaelin Jr","year":"2009","journal-title":"Cancer Cell"},{"key":"2019041200564011600_R32","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1128\/MCB.02246-06","article-title":"BNIP3 is an RB\/E2F target gene required for hypoxia-induced autophagy.","volume":"27","author":"Tracy","year":"2007","journal-title":"Mol Cell Biol"},{"key":"2019041200564011600_R33","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1210\/jc.2008-2756","article-title":"Genetics of pheochromocytoma and paraganglioma in Spanish patients.","volume":"94","author":"Cascon","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041200564011600_R34","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/bioinformatics\/btm412","article-title":"A comparison of background correction methods for two-colour microarrays.","volume":"23","author":"Ritchie","year":"2007","journal-title":"Bioinformatics"},{"key":"2019041200564011600_R35","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/bioinformatics\/bti270","article-title":"Use of within-array replicate spots for assessing differential expression in microarray experiments.","volume":"21","author":"Smyth","year":"2005","journal-title":"Bioinformatics"},{"key":"2019041200564011600_R36","author":"Montaner"},{"key":"2019041200564011600_R37","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/bioinformatics\/bth138","article-title":"GeneCluster 2.0: an advanced toolset for bioarray analysis.","volume":"20","author":"Reich","year":"2004","journal-title":"Bioinformatics"},{"key":"2019041200564011600_R38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1023949509487","article-title":"Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data.","volume":"52","author":"Monti","year":"2003","journal-title":"Mach Learn"},{"key":"2019041200564011600_R39","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1093\/nar\/gkp425","article-title":"An integrative genomics approach identifies hypoxia inducible factor-1 (HIF-1)-target genes that form the core response to hypoxia.","volume":"37","author":"Benita","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"2019041200564011600_R40","author":"Morrissey"},{"key":"2019041200564011600_R41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","article-title":"Controlling the false discovery rate in behavior genetics research.","volume":"125","author":"Benjamini","year":"2001","journal-title":"Behav Brain Res"},{"key":"2019041200564011600_R42","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041200564011600_R43","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","article-title":"Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.","volume":"93","author":"Herman","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041200564011600_R44","first-page":"4366","article-title":"Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer.","volume":"60","author":"Esteller","year":"2000","journal-title":"Cancer Res"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/24\/12\/2382\/10721803\/mend2382.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T19:42:09Z","timestamp":1555098129000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/24\/12\/2382\/2738107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,1]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2010-0256","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,1]]}}}